Phase I Clinical Trial to Assess the Safety and Pharmacokinetic Profile of CKD-516 in Patients With Advanced Solid Cancers Failed to Standard Therapy
Latest Information Update: 28 Dec 2011
Price :
$35 *
At a glance
- Drugs Valecobulin (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 28 Dec 2011 New trial record